How effective is Stem Cell Therapy for Erectile Dysfunction?
Stem cell therapy for erectile dysfunction (ED) has shown encouraging early results. Human studies report improvements in erectile function scores and penile blood flow in some men, with a favorable short-term safety profile.

A 2024 review in the Asian Journal of Urology identified 11 human trials; most reported improvement. Major urology guidelines continue to focus on established ED treatments, while regenerative therapy remains an emerging option supported by a growing body of early human research. At Stem Cell Mexico, regenerative protocols for ED use only allogeneic mesenchymal stem cells (MSCs) from Wharton's jelly of the umbilical cord and are designed to complement the patient's broader sexual and cardiovascular health plan.
This guide explains how ED treatment effectiveness is measured, what the research shows, how regenerative therapy compares with established treatments and which factors influence results.
How effectiveness is measured in ED
Researchers and urologists use standardized tools:
- International Index of Erectile Function (IIEF), including the short IIEF-5 or SHIM: a questionnaire scoring erectile function, with higher scores meaning better function. Changes of a few points can be meaningful depending on baseline severity.
- Erection Hardness Score (EHS): a simple 1 to 4 scale of rigidity.
- Penile Doppler ultrasound: measures blood flow in the penile arteries before and after stimulation.
- Sexual encounter diaries: record the proportion of successful attempts.
- Need for medication: whether men can reduce or stop oral ED drugs.
When evaluating a claim, it is useful to ask which measure improved, by how much, for how long and compared with what.
What the research shows
Human studies
The 2024 Asian Journal of Urology review summarized human trials using different cell types, including bone marrow, adipose and umbilical cord-derived cells, injected into the erectile tissue (intracavernous injection). Key points:
- Improvement: most studies reported increases in IIEF scores and, in some, better penile blood flow.
- Safety: no major side effects were reported; temporary discomfort and bruising were common.
- Conclusion: promising, especially for men who do not respond to standard treatment.
Guidelines
- EAU guidelines: safety has been confirmed in trials, and stem cell therapy is not yet included among standard recommendations. The same guidelines advise that intracavernous platelet-rich plasma (PRP) be used in a clinical trial setting.
- AUA guideline: does not yet include stem cell therapy or PRP among standard treatments.
What this means
Regenerative therapy for ED has shown encouraging early signals and good short-term safety, and it is designed to complement established treatments. Individual results vary.
How it compares with established treatments
Proven ED treatments, supported by large randomized trials and guidelines, include:
- Oral PDE5 inhibitors (sildenafil, tadalafil and similar), which are effective for many men and are first-line therapy.
- Lifestyle changes: weight loss, exercise, smoking cessation, reduced alcohol and management of diabetes, blood pressure and cholesterol, which can improve erectile function and overall health.
- Treatment of low testosterone when confirmed, in combination with other therapies.
- Vacuum erection devices.
- Intracavernous injections of vasoactive drugs, which work on demand.
- Penile prosthesis surgery for men who do not respond to other options, a long-established and durable solution.
Unlike these treatments, which act on demand or provide a mechanical solution, regenerative therapy aims to improve the underlying tissue.
Combined approaches: PRP and shockwave therapy
Regenerative ED protocols are sometimes combined with other treatments:
- Platelet-rich plasma (PRP): prepared from your own blood; it contains growth factors but no stem cells.
- Low-intensity shockwave therapy (Li-ESWT): applies low-energy sound waves to the penis to stimulate blood vessel formation.
Combining treatments does not automatically make them more effective, and each component has its own evidence and risks. Your written plan should state clearly what is included and why.
Factors that influence results
- Cause of ED: vasculogenic ED (reduced blood flow) and mild to moderate ED are the most frequently studied. ED after prostate cancer surgery, severe nerve damage or advanced diabetes may respond less.
- Severity: men with mild to moderate ED may be more likely to notice improvement than those with severe ED.
- Cardiovascular risk factors: uncontrolled diabetes, high blood pressure, high cholesterol, smoking and obesity continue to damage blood vessels and can limit any benefit.
- Hormones: untreated low testosterone can limit results.
- Psychological factors: anxiety, depression and relationship stress affect erections regardless of tissue health.
- Expectations: regenerative therapy aims at function, not penile enlargement.
A realistic timeline
- First days: mild discomfort or bruising at the injection site.
- Weeks to months: if improvement occurs, it is usually gradual; studies have typically evaluated outcomes between 1 and 12 months.
- Long term: durability varies, and follow-up helps decide whether a second session is useful.
What a meaningful improvement looks like
For an individual man, effectiveness is best judged against personal goals. Examples include firmer erections that are reliable enough for intercourse, less dependence on medication, the ability to maintain an erection longer or more spontaneity in sexual activity. Recording your IIEF-5 score and a brief diary of sexual encounters before treatment makes it possible to compare objectively afterward, rather than relying on memory.
ED as a sign of heart health
Because the penile arteries are small, ED can be an early warning sign of cardiovascular disease, sometimes appearing years before heart problems. The National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK, NIH) lists heart disease, diabetes, chronic kidney disease and hormone issues among the conditions linked to ED. A cardiovascular risk assessment is an important part of any ED evaluation.
How Stem Cell Mexico approaches ED
- Cells: allogeneic MSCs from Wharton's jelly of donated umbilical cords, obtained after healthy, full-term births with informed consent and donor screening. No autologous cells or other cell sources are used.
- Laboratory: produced in a COFEPRIS-licensed laboratory under Good Manufacturing Practice standards, with quality and safety testing before release.
- Evaluation: history, IIEF-5 questionnaire, cardiovascular risk factors, medications and hormone testing including morning testosterone.
- Treatment: intracavernous application under local anesthesia, as described in your written plan.
- Follow-up: repeat IIEF-5 and, when appropriate, other measures at about 1, 3 and 6 months.
- Outcome tracking: effectiveness is followed with the IIEF-5, patient-reported function and, when appropriate, Doppler or medication-response changes. Tracking the same measures before and after treatment provides a more meaningful picture than a single generalized success percentage.
Safety
Reported side effects include temporary discomfort, bruising and swelling. Rare risks include infection, bleeding, a prolonged erection (priapism) that requires urgent care and scarring of erectile tissue. No treatment is free of risk. Men taking blood thinners or ED medications should discuss them with the doctor before treatment, who will indicate whether and when to take them around the procedure.
Who may be a candidate
- Men with mild to moderate ED, especially of vascular origin, who have been evaluated for underlying causes.
- Men who respond poorly to, do not tolerate or wish to explore alternatives to oral medications, with realistic expectations.
- Controlled diabetes, blood pressure and cholesterol.
- No active infection, untreated penile curvature disorder requiring surgery or cancer within the past five years.
Warning signs when comparing clinics
Be cautious if a clinic promises permanent results, penile enlargement or a cure; reports success rates without published data; does not assess cardiovascular risk or testosterone; or says the treatment is risk-free.
What our patients usually receive
Based on the treatment plans our team prepares for patients, a typical protocol at Stem Cell Mexico includes:
- Wharton's jelly MSCs applied by direct injection under local anesthesia, often together with platelet-rich plasma (PRP); your written plan specifies the number of cells and sessions.
- A private, confidential visit, with consultation with your doctor and the stem cell specialist and pre-treatment laboratory tests.
- Ground transportation from the San Diego airport area and, when your plan includes it, a night at our facilities with nursing and medical monitoring.
Recovery is gradual, and each man responds differently. Our team stays in contact after treatment to follow your progress and decide whether an additional session could help. If you take oral ED medication, the doctor will tell you whether and when to take it around the procedure, and you can continue your usual treatment afterward unless advised otherwise. Your follow-up includes repeating the same IIEF-5 questionnaire you completed before treatment.
Questions to ask during your evaluation
- What is the most likely cause of my ED?
- Have I tried proven treatments, and how did I respond?
- What results are realistic for my severity and cause of ED?
- How will results be measured, and when?
- What are the risks in my situation?
Bottom line
Stem cell therapy for erectile dysfunction has shown encouraging early human results and a favorable short-term safety profile. It can be considered as a regenerative option for selected men, particularly when the goal is to support vascular and tissue health while continuing to manage the underlying causes of ED. A medical evaluation can help determine whether this approach fits your sexual health concerns, goals and medical history and how progress should be measured.
References
- Abou Chakra M et al. An update on the use of stem cell therapy for erectile dysfunction. Asian Journal of Urology, 2024 (opens in a new tab)
- European Association of Urology (EAU) Guidelines on Sexual and Reproductive Health: Management of erectile dysfunction (opens in a new tab)
- American Urological Association (AUA): Erectile Dysfunction Guideline (opens in a new tab)
- National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK, NIH): Symptoms and causes of erectile dysfunction (opens in a new tab)
